These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20354542)

  • 1. Chemotherapy: How useful is adjuvant irinotecan in stage IV CRC?
    Loupakis F; Falcone A
    Nat Rev Clin Oncol; 2010 Apr; 7(4):190-1. PubMed ID: 20354542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new chemotherapy of colorectal cancers].
    Taïeb J; Boige V; Ducreux M
    Presse Med; 2002 Jan; 31(3):132-8. PubMed ID: 11859739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases.
    Ychou M; Viret F; Kramar A; Desseigne F; Mitry E; Guimbaud R; Delpero JR; Rivoire M; Quénet F; Portier G; Nordlinger B
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):195-201. PubMed ID: 17901955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study.
    Seium Y; Stupp R; Ruhstaller T; Gervaz P; Mentha G; Philippe M; Allal A; Trembleau C; Bauer J; Morant R; Roth AD
    Ann Oncol; 2005 May; 16(5):762-6. PubMed ID: 15817597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases.
    Liu JH; Hsieh YY; Chen WS; Hsu YN; Chau GY; Teng HW; King KL; Lin TC; Tzeng CH; Lin JK
    Int J Colorectal Dis; 2010 Oct; 25(10):1243-9. PubMed ID: 20574727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second line therapies move to the forefront in colorectal cancer.
    Miller M
    J Natl Cancer Inst; 1999 Jun; 91(12):998-1000. PubMed ID: 10379961
    [No Abstract]   [Full Text] [Related]  

  • 8. What's new in ... colorectal cancer. Meaningful progress in therapy options.
    Polansky M; Ross AC
    JAAPA; 2009 Apr; 22(4):51-2. PubMed ID: 19452823
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparing time to disease progression of irinotecan and oxaliplatin-based chemotherapies in colorectal cancer patients with liver only metastasis.
    Varol U; Karaca B; Cakar B; Sezgin C; Karabulut B; Uslu R
    Am J Clin Oncol; 2013 Aug; 36(4):388-91. PubMed ID: 22643568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre study of perioperative
    Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K
    BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy for colorectal cancers].
    Lièvre A; Mitry E
    J Chir (Paris); 2003 Feb; 140(1):52-5. PubMed ID: 12709655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.
    Martin RC; Scoggins CR; Tomalty D; Schreeder M; Metzger T; Tatum C; Sharma V
    J Gastrointest Surg; 2012 Aug; 16(8):1531-8. PubMed ID: 22528576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.
    Liang XB; Hou SH; Li YP; Wang LC; Zhang X; Yang J
    Chin Med J (Engl); 2010 Nov; 123(22):3314-8. PubMed ID: 21163137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
    Comella P; Massidda B; Natale D; Putzu C; Sandomenico C; Filippelli G; Palmeri S; Condemi G; Vessia G; Barberis G; Ionta MT; Tafuto S; Barbato E
    Clin Colorectal Cancer; 2011 Mar; 10(1):42-7. PubMed ID: 21609935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
    Grivicich I; Mans DR; Peters GJ; Schwartsmann G
    Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic treatment of colorectal cancers--factual standards and perspectives].
    Miron L
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):752-8. PubMed ID: 14756014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor status at 12 weeks predicts survival in advanced colorectal cancer: findings from NCCTG N9741.
    Heun JM; Grothey A; Branda ME; Goldberg RM; Sargent DJ
    Oncologist; 2011; 16(6):859-67. PubMed ID: 21632455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer.
    Saif MW
    World J Gastroenterol; 2009 Aug; 15(31):3855-64. PubMed ID: 19701965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy: Optimizing irinotecan regimens for colorectal cancer.
    Yim KL; Cunningham D
    Nat Rev Clin Oncol; 2009 Oct; 6(10):560-1. PubMed ID: 19786997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.